- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, NUBURU, a supplier of high-power and high brightness industrial blue laser technology in the United States, announced that it has reached bridge loan agreements ("bridge loans" or "bridge financing") with existing and new institutional investors.The principal of this bridge financing is $5.5 million, aimed at providing funding for the company until it obtains long-term credit financing,...
A muffler is a key component of a car's exhaust system, designed to reduce noise levels and emissions. The vibration of a muffler can have a significant impact on its performance and life. In order to understand the performance and behavior of the muffler, it is necessary to make multi-point vibration measurement. First, it enables engineers to assess the structural integrity and durability of a m...
Recently, scientists from the National Ignition Facility at Lawrence Livermore National Laboratory in California produced a burst of energy by bombarding hydrogen pellets with 192 laser beams, briefly reproducing the fusion process that powers the sun. This is a repeat of an experiment in December last year, but this time the scientists generated more energy, with a gain almost double that of the ...
The First Ultra Fast Laser Application Development Conference was held in Songshan Lake, Dongguan. The first advanced attosecond laser facility in China will have 8 beam lines landing in Dongguan.Laser enjoys the reputation of being the "fastest knife," "most accurate ruler," and "brightest light," among others. As an important research direction in the laser field, ultrafast laser has always been...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...